Leerink Swann Starts Anthera Pharma (ANTH) at Outperform; Compelling Risk-Reward with Advanced Programs in SLE and ACS

Go back to Leerink Swann Starts Anthera Pharma (ANTH) at Outperform; Compelling Risk-Reward with Advanced Programs in SLE and ACS